COMMUNIQUÉS West-GlobeNewswire

ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
27/05/2026
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, May 27, 2026 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of [...]
MannKind to Present at Jefferies Global Healthcare Conference
27/05/2026
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., May 27, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) , announced today that Chief Executive Officer, Michael Castagna, PharmD will participate in a fireside [...]
Ligand to Participate in June Investor Conferences
27/05/2026
JUPITER, Fla., May 27, 2026 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that its senior management team will participate in the following upcoming investor conferences: Stifel [...]
BrewDog transforme le tournoi mondial de football de cet été en une célébration nationale de la bière, des bars et des grands moments de match
27/05/2026
BrewDog lance une campagne multicanale baptisée « Underdog » dans les points de vente, les bars et les médias numériques, avec notamment un concours national « Win a Year of Beer », ainsi que des soirées de [...]
Supernus Pharmaceuticals to Participate in June Investor Conferences
27/05/2026
ROCKVILLE, Md., May 27, 2026 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system [...]
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in June
27/05/2026
CAMBRIDGE, Mass., May 27, 2026 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies for patients living [...]
CVRx to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
27/05/2026
MINNEAPOLIS, May 27, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions [...]
Combined General Meeting of May 27, 2026
27/05/2026
Press Release - Approval of all resolutions submitted by the Board of Directors - Paris – May 27, 2026 – The Combined General Meeting of EUROAPI Shareholders was held on May 27, 2026 in Paris, under the chairmanship of [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 21 - 2026
27/05/2026
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 18 mai au 22 mai 202 6 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction Code [...]
Vigortrix Male Enhancement Claims Evaluated: The Horse Gelatin Trick for Men's Stallion-Like Vigor Boost Performance Support
27/05/2026
VigorTrix Ingredients Explained: L-Citrulline, Maca Root, Pine Bark, Velvet Bean, and Saffron in a Men's Vitality and Stamina Supplement With a 60-Day Money-Back Guarantee Aurora, CO, May 27, 2026 (GLOBE NEWSWIRE) -- [...]
Assemblée Générale Mixte du 27 mai 2026
27/05/2026
Communiqué de presse - Approbation de l’ensemble des résolutions proposées par le Conseil d’administration - Paris – Le 27 mai 2026 - L’Assemblée Générale Mixte des actionnaires d’EUROAPI s’est réunie le 27 mai 2026 à [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 21 - 2026
27/05/2026
Aggregated presentation by day and by market Purchases of own shares from May 18th to May 22nd 2026 Name of the Issuer Identity code of the Issuer Day of the transaction Identity code of the financial instrument Total [...]
New REDUCE-IT® Analysis Presented at the European Atherosclerosis Society (EAS) Congress 2026 Suggests Risk-Weighted ApoB May Improve Identification of Residual Cardiovascular Risk in Statin-Treated Patients with Hypertriglyceridemia
27/05/2026
DUBLIN and BRIDGEWATER, N.J., May 27, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN) (Amarin), a company committed to advancing the science of cardiovascular disease (CVD) worldwide, today announced new [...]
Callio Therapeutics to Present Phase 1 Trial Design of CLIO-8221, Novel Dual-Payload ADC, at ASCO 2026
27/05/2026
SEATTLE and SINGAPORE, May 27, 2026 (GLOBE NEWSWIRE) -- Callio Therapeutics, a biotherapeutics company advancing dual-payload antibody-drug conjugates (ADCs) with a targeted, multi-mechanism approach to cancer treatment [...]
20/20 Biolabs' Multi-Cancer Early Detection Blood Test Selected by State of Vermont to Screen up to 4,500 Firefighters
27/05/2026
Comprehensive Cancer Screening Initiative Expected to Generate Approximately $500,000 in Testing Revenues to 20/20 from the First Cohort GAITHERSBURG, Md., May 27, 2026 (GLOBE NEWSWIRE) -- 20/20 Biolabs, Inc. (Nasdaq: [...]
AIM ImmunoTech Announces Emerging Ebola Opportunity for Ampligen Amid Escalating Global Health Concerns and WHO Emergency Declaration
27/05/2026
Previously published Biosafety Level 4 pre-clinical study showed 100% survival with early treatment following infection in a mouse model following lethal doses of Ebola Company to release Virtual Investor “Ebola: What [...]
Milestone Scientific Highlights Growing Clinical Adoption and Expanding Physician Acceptance of CompuFlo® Across Epidural, Neuromodulation, and Interventional Pain Procedures
27/05/2026
ROSELAND, N.J., May 27, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug delivery instruments utilizing Dynamic Pressure Sensing™ (DPS) technology, today [...]
Join BioVie’s Exclusive Live Investor Webinar and Q and A Session on June 2
27/05/2026
CARSON CITY, Nev., May 27, 2026 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and neurodegenerative diseases, [...]
CDT Announces Canadian Patent for AZD5904 in Male Infertility
27/05/2026
NAPLES, Fla. and CAMBRIDGE, United Kingdom, May 27, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today announces that the patent covering the use of AZD5904 in male infertility has [...]

Pages